Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06529783
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-26
Brief Title:
Ultrasound-Guided Percutaneous Neuromodulation on the Superior Gluteal Nerve in Patients With Greater Trochanteric Pain Syndrome A Pilot Study
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effectiveness of Ultrasound-Guided Percutaneous Neuromodulation UG-PNM on the Superior Gluteal Nerve in Patients With Greater Trochanteric Pain Syndrome GTPS A Pilot Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Greater Trochanteric Pain Syndrome GTPS predominantly affects women with an annual incidence of 18 to 56 per 1000 individuals and a prevalence ratio of 41 compared to men It is characterized by lateral pain in the greater trochanter region particularly during palpation prolonged sitting and physical activity Conservative treatments such as radial shockwave therapy and therapeutic exercises are effective but slow and some patients eventually require surgery
Ultrasound-guided percutaneous neuromodulation targeting the superior gluteal nerve has emerged as a promising alternative to improve GTPS outcomes This technique aims to normalize motor response and reduce pain more rapidly than conventional therapies Integrating neuromodulation could accelerate recovery enhancing both pain relief and tendon functionality This study aims to explore the effectiveness of this technique as an adjunct to conventional treatments aiming for faster symptom improvement and better long-term adherence
Ultrasound-guided percutaneous neuromodulation targeting the superior gluteal nerve has emerged as a promising alternative to improve GTPS outcomes This technique aims to normalize motor response and reduce pain more rapidly than conventional therapies Integrating neuromodulation could accelerate recovery enhancing both pain relief and tendon functionality This study aims to explore the effectiveness of this technique as an adjunct to conventional treatments aiming for faster symptom improvement and better long-term adherence
Detailed Description:
Greater Trochanteric Pain Syndrome GTPS is a condition primarily affecting women with an annual incidence ranging from 18 to 56 per 1000 individuals and a prevalence ratio of 41 compared to men Formerly known as trochanteric bursitis this syndrome is characterized by lateral pain in the region of the greater trochanter particularly manifesting during palpation prolonged sitting and physical activity The primary cause of GTPS is attributed to repetitive friction between the greater trochanter and the iliotibial band resulting in gluteus medius or minimus tendinopathy as well as other associated conditions such as trochanteric bursitis and iliotibial band syndrome
Conservative treatment is the first-line approach for GTPS with radial shockwave therapy and therapeutic exercises demonstrating long-term efficacy However a percentage of patients require surgical intervention due to a lack of response to conservative treatments
Ultrasound-guided percutaneous neuromodulation a technique utilizing electrical stimulation via a needle guided by ultrasound has emerged as a potential alternative to improve therapeutic outcomes for GTPS In this study this technique targets the superior gluteal nerve which innervates the gluteus medius minimus and tensor fasciae latae with the aim of normalizing motor response and reducing pain Neuromodulation could provide a faster improvement in symptoms and motor patterns compared to conventional therapies which require prolonged periods to be effective
Given that current treatments for GTPS such as shockwave therapy and therapeutic exercises are effective but slow in progress the integration of percutaneous neuromodulation could accelerate patient recovery improving both pain relief and mechanical functionality of the tendon This combined approach has the potential not only to optimize clinical outcomes but also to reduce the need for surgical interventions in GTPS patients
In summary this study proposes to explore the effectiveness of superior gluteal nerve neuromodulation as an adjunct to conventional treatments for GTPS The research aims to demonstrate whether this technique can significantly expedite pain reduction and motor pattern improvement thereby enhancing long-term treatment adherence and tolerance
Conservative treatment is the first-line approach for GTPS with radial shockwave therapy and therapeutic exercises demonstrating long-term efficacy However a percentage of patients require surgical intervention due to a lack of response to conservative treatments
Ultrasound-guided percutaneous neuromodulation a technique utilizing electrical stimulation via a needle guided by ultrasound has emerged as a potential alternative to improve therapeutic outcomes for GTPS In this study this technique targets the superior gluteal nerve which innervates the gluteus medius minimus and tensor fasciae latae with the aim of normalizing motor response and reducing pain Neuromodulation could provide a faster improvement in symptoms and motor patterns compared to conventional therapies which require prolonged periods to be effective
Given that current treatments for GTPS such as shockwave therapy and therapeutic exercises are effective but slow in progress the integration of percutaneous neuromodulation could accelerate patient recovery improving both pain relief and mechanical functionality of the tendon This combined approach has the potential not only to optimize clinical outcomes but also to reduce the need for surgical interventions in GTPS patients
In summary this study proposes to explore the effectiveness of superior gluteal nerve neuromodulation as an adjunct to conventional treatments for GTPS The research aims to demonstrate whether this technique can significantly expedite pain reduction and motor pattern improvement thereby enhancing long-term treatment adherence and tolerance
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None